Potent T cell response to a class I-binding 13-mer viral epitope and the influence of HLA micropolymorphism in controlling epitope length

European Journal of Immunology

Volumn 34, Issue 9, 2004, Pages 2510-2519

  Green, Kate J ^a   Miles, John J ^a   Tellam, Judy ^a   van Zuylen, Wendy J M ^a   Connolly, Geoff ^a   Burrows, Scott R ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Antigen presentation; CTL; Human; MHC; Processing; Viral

Indexed keywords

ARGININE; EPITOPE; LEUCINE; LEUKOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS ANTIGEN; BZLF1 PROTEIN, HERPESVIRUS 4, HUMAN; DNA BINDING PROTEIN; HLA B35 ANTIGEN; PEPTIDE FRAGMENT; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ALLELE; AMINO ACID ANALYSIS; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE SEQUENCE; GENE TARGETING; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOGENICITY; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; T LYMPHOCYTE; ANTIGEN PRESENTATION; CELL LINE; CYTOTOXIC T LYMPHOCYTE; GENETIC POLYMORPHISM; IMMUNOLOGY; METABOLISM;

ANTIGEN PRESENTATION; CELL LINE; DNA-BINDING PROTEINS; EPITOPES, T-LYMPHOCYTE; HERPESVIRUS 4, HUMAN; HLA-B35 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; PEPTIDE FRAGMENTS; POLYMORPHISM, GENETIC; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANS-ACTIVATORS; VIRAL PROTEINS;

EID: 4644272170     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425193     Document Type: Article

References (28)

1. Yewdell, J. W. and Bennink, J. R., Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 1999. 17: 51-88.
2. Saper, M. A., Bjorkman, P. and Wiley, D. C., Refined structure of the human histocompatibility antigen HLA-A2 at 2.6A resolution. J. Mol. Biol. 1991. 219: 277-319.
3. Hill, A. V., Elvin, J., Willis, A. C., Aidoo, M., Allsopp, C. E., Gotch, F. M., Gao, X. M., Takiguchi, M., Greenwood, B. M., Townsend, A. R., McMichael, A. J. and Whittle, H. C., Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992. 360: 434-439.
4. Falk, K., Rotzschke, O., Grahovac, B., Schendel, D., Stevanovic, S., Jung, G. and Rammensee, H. G., Peptide motifs of HLA-B35 and -B37 molecules. Immunogenetics 1993. 38: 161-162.
5. Schonbach, C., Miwa, K., Ibe, M., Shiga, H., Nokihara, K. and Takiguchi, M., Refined peptide HLA-B*3501 binding motif reveals differences in 9-mer to 11-mer peptide binding. Immunogenetics 1996. 45: 121-129.
6. Urban, R. G., Chicz, R. M., Lane, W. S., Strominger, J. L., Rehm, A., Kenter, M. J., UytdeHaag, F. G., Ploegh, H., Uchanska-Ziegler, B. and Ziegler, A., A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc. Natl. Acad. Sci. USA 1994. 91: 1534-1538.
7. Stryhn, A., Pedersen, L. O., Holm, A. and Buus, S., Longer peptide can be accommodated in the MHC class I binding site by a protrusion mechanism. Eur. J. Immunol. 2000. 30: 3089-3099.
8. Guo, H. C., Jardetzky, T. S., Garrett, T. P., Lane, W. S., Strominger, J. L. and Wiley, D. C., Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 1992. 360: 364-366.
9. Speir, J. A., Stevens, J., Joly, E., Butcher, G. W. and Wilson, I. A., Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-Aa. Immunity 2001. 14: 81-92.
10. Probst-Kepper, M., Stroobant, V., Kridel, R., Gaugler, B., Landry, C., Brasseur, F., Cosyns, J. P., Weynand, B., Boon, T. and van den Eynde, B. J., An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes. J. Exp. Med. 2001. 193: 1189-1198.
11. b heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria. J. Immunol. 1999. 163: 4434-4441.
12. Chen, Y., Sidney, J., Southwood, S., Cox, A. L., Sakaguchi, K., Henderson, R. A., Appella, E., Hunt, D. F., Sette, A. and Engelhard, V. H., Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations. J. Immunol. 1994. 152: 2874-2881.
13. Pamer, E. and Cresswell, P., Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 1998. 16: 323-358.
14. Serwold, T., Gaw, S. and Shastri, N., ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. Nat. Immunol. 2001. 2: 644-651.
15. Wenzel, T., Eckerskorn, C., Lottspeich, F. and Baumeister, W., Existence of a molecular ruler in proteasomes suggested by analysis of degradation products. FEBS Lett. 1994. 349: 205-209.
16. Uebel, S., Kraas, W., Kienle, S., Wiesmuller, K. H., Jung, G. and Tampe, R., Recognition principle of the TAP transporter disclosed by combinatorial peptide libraries. Proc. Natl. Acad. Sci. USA 1997. 94: 8976-8981.
17. Androlewicz, M. J. and Cresswell, P., How selective is the transporter associated with antigen processing? Immunity 1996. 5: 1-5.
18. Serwold, T., Gonzalez, F., Kim, J., Jacob, R. and Shastri, N., ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 2002. 419: 480-483.
19. Khanna, R. and Burrows, S. R., Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases. Annu. Rev. Microbiol. 2000. 54: 19-48.
20. + T cells specific for EBV in healthy virus carriers. J. Immunol. 1999. 162: 1827-1835.
21. Saulquin, X., Ibisch, C., Peyrat, M. A., Scotet, E., Hourmant, M., Vie, H., Bonneville, M. and Houssaint, E., A global appraisal of immunodominant CD8 T cell responses to Epstein-Barr virus and cytomegalovirus by bulk screening. Eur. J. Immunol. 2000. 30: 2531-2539.
22. Ragupathi, G., Cereb, N. and Yang, S. Y., The relative distribution of B35 alleles and their IEF isotypes in a HLA-B35-positive population. Tissue Antigens 1995. 46: 24-31.
23. Steinle, A., Falk, K., Rotzschke, O., Gnau, V., Stevanovic, S., Jung, G., Schendel, D. J. and Rammensee, H. G., Motif of HLA-B* 3503 peptide ligands. Immunogenetics 1996. 43: 105-107.
24. DiBrino, M., Parker, K. C., Shiloach, J., Knierman, M., Lukszo, J., Turner, R. V., Biddison, W. E. and Coligan, J. E., Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. Proc. Natl. Acad. Sci. USA 1993. 90: 1508-1512.
25. Kesmir, C., Nussbaum, A. K., Schild, H., Detours, V. and Brunak, S., Prediction of proteasome cleavage motifs by neural networks. Protein Eng. 2002. 15: 287-296.
26. Salter, R. D. and Cresswell, P., Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J. 1986. 5: 943-949.
27. Khanna, R., Silins, S. L., Weng, Z., Gatchell, D., Burrows, S. R. and Cooper, L., Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction. Eur. J. Immunol. 1999. 29: 1587-1597.
28. Burrows, S. R., Silins, S. L., Moss, D. J., Khanna, R., Misko, I. S. and Argaet, V. P., T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J. Exp. Med. 1995. 182: 1703-1715.